Literature DB >> 21070859

Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis.

Luke C Kingry1, Ryan M Troyer, Nicole L Marlenee, Helle Bielefeldt-Ohmann, Richard A Bowen, Alan R Schenkel, Steven W Dow, Richard A Slayden.   

Abstract

Francisella tularensis is a category A select agent based on its infectivity and virulence but disease mechanisms in infection remain poorly understood. Murine pulmonary models of infection were therefore employed to assess and compare dissemination and pathology and to elucidate the host immune response to infection with the highly virulent Type A F. tularensis strain Schu4 versus the less virulent Type B live vaccine strain (LVS). We found that dissemination and pathology in the spleen was significantly greater in mice infected with F. tularensis Schu4 compared to mice infected with F. tularensis LVS. Using gene expression profiling to compare the response to infection with the two F. tularensis strains, we found that there were significant differences in the expression of genes involved in the apoptosis pathway, antigen processing and presentation pathways, and inflammatory response pathways in mice infected with Schu4 when compared to LVS. These transcriptional differences coincided with marked differences in dissemination and severity of organ lesions in mice infected with the Schu4 and LVS strains. Therefore, these findings indicate that altered apoptosis, antigen presentation and production of inflammatory mediators explain the differences in pathogenicity of F. tularensis Schu4 and LVS.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21070859      PMCID: PMC3031720          DOI: 10.1016/j.micinf.2010.10.022

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  46 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics.

Authors:  E L OVERHOLT; W D TIGERTT; P J KADULL; M K WARD; N D CHARKES; R M RENE; T E SALZMAN; M STEPHENS
Journal:  Am J Med       Date:  1961-05       Impact factor: 4.965

3.  A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Authors:  Susan Twine; Mona Byström; Wangxue Chen; Mats Forsman; Igor Golovliov; Anders Johansson; John Kelly; Helena Lindgren; Kerstin Svensson; Carl Zingmark; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Francisella tularensis induces aberrant activation of pulmonary dendritic cells.

Authors:  Catharine M Bosio; Steven W Dow
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 5.  Tularemia: emergence/re-emergence.

Authors:  Jeannine M Petersen; Martin E Schriefer
Journal:  Vet Res       Date:  2005 May-Jun       Impact factor: 3.683

6.  Pathogenesis of tularemia in immune and nonimmune rats.

Authors:  J B Moe; P G Canonico; J L Stookey; M C Powanda; G L Cockerell
Journal:  Am J Vet Res       Date:  1975-10       Impact factor: 1.156

Review 7.  Mouse Ly49 NK receptors: balancing activation and inhibition.

Authors:  John R Ortaldo; Howard A Young
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Live vaccine strain of Francisella tularensis: infection and immunity in mice.

Authors:  A H Fortier; M V Slayter; R Ziemba; M S Meltzer; C A Nacy
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  The lectin-like receptor KLRE1 inhibits natural killer cell cytotoxicity.

Authors:  Ingunn H Westgaard; Erik Dissen; Knut M Torgersen; Sasha Lazetic; Lewis L Lanier; Joseph H Phillips; Sigbjorn Fossum
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  12 in total

1.  Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.

Authors:  Donald J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  The Francisella tularensis FabI enoyl-acyl carrier protein reductase gene is essential to bacterial viability and is expressed during infection.

Authors:  Luke C Kingry; Jason E Cummings; Kerry W Brookman; Gopal R Bommineni; Peter J Tonge; Richard A Slayden
Journal:  J Bacteriol       Date:  2012-11-09       Impact factor: 3.490

3.  Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.

Authors:  Sherry L Kurtz; Oded Foreman; Catharine M Bosio; Miriam R Anver; Karen L Elkins
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

4.  Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis.

Authors:  Susan E Knudson; Jason E Cummings; Gopal R Bommineni; Pan Pan; Peter J Tonge; Richard A Slayden
Journal:  Tuberculosis (Edinb)       Date:  2016-08-03       Impact factor: 3.131

5.  Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Authors:  Jerod A Skyberg; Maryclare F Rollins; Joshua W Samuel; Marjorie D Sutherland; John T Belisle; David W Pascual
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

6.  Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.

Authors:  Jerod A Skyberg; MaryClare F Rollins; Jeff S Holderness; Nicole L Marlenee; Igor A Schepetkin; Andrew Goodyear; Steven W Dow; Mark A Jutila; David W Pascual
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

7.  Border Patrol Gone Awry: Lung NKT Cell Activation by Francisella tularensis Exacerbates Tularemia-Like Disease.

Authors:  Timothy M Hill; Pavlo Gilchuk; Basak B Cicek; Maria A Osina; Kelli L Boyd; Douglas M Durrant; Dennis W Metzger; Kamal M Khanna; Sebastian Joyce
Journal:  PLoS Pathog       Date:  2015-06-11       Impact factor: 6.823

8.  Francisella tularensis subsp. tularensis induces a unique pulmonary inflammatory response: role of bacterial gene expression in temporal regulation of host defense responses.

Authors:  Kathie-Anne Walters; Rachael Olsufka; Rolf E Kuestner; Ji Hoon Cho; Hong Li; Gregory A Zornetzer; Kai Wang; Shawn J Skerrett; Adrian Ozinsky
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

9.  The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infection.

Authors:  Alan Rowe Schenkel; Luke C Kingry; Richard A Slayden
Journal:  Front Immunol       Date:  2013-04-16       Impact factor: 7.561

10.  TPR1, a novel rifampicin derivative, demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A priority pathogen Francisella tularensis.

Authors:  Jason E Cummings; Keaton W Slayden; Richard A Slayden
Journal:  JAC Antimicrob Resist       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.